Psychedelics | Ekaterina Malievskaia (Compass Pathways), Cosmo Feilding Mellen (Beckley Psytech)
Channel: Slush
Date: 05/12/2023

Psychedelics — The New Psychiatric Frontier

Psychedelics and mental health share a common thread. Both historically stigmatised, they are today witnessing a growth in interest and investment. But what happens when these two worlds intersect? With emerging research signaling the potential therapeutic benefits of psychedelics for conditions like depression and PTSD, there is new hope for patients in need - and new challenges for regulators and healthcare systems.

With Cate Lawrence of Tech.eu guiding the conversation, join Cosmo Feilding Mellen, CEO and co-founder of Beckley Psytech, and Ekaterina Malievskaia, co-founder of Compass Pathways, to learn how these companies are navigating the maze of psychedelic treatment development whilst pursuing their steadfast vision of patient access.

---
Slush is the most founder-focused event on earth delivering actionable company-building advice and bringing together the who’s who in the ecosystem.

Want to join us at Slush in 2024? Pre-register here: slush.org/pre-register

Want even more? Follow us on social media.
Linkedin: linkedin.com/company/slush
Instagram: instagram.com/slushhq
Twitter: twitter.com/SlushHQ
---
Thumbnail photo (c) Jessica North